Federal Circuit Upholds Corning’s Patent Victory in Gene Therapy Legal Dispute

The U.S. Court of Appeals for the Federal Circuit has turned down an appeal from a Minnesota-based gene therapy developer, maintaining a victory for Corning Inc. in a patent dispute. The appellant argued that it was wrongly denied a jury trial in the case concerning the attribution of patents to Corning’s name. This decision is a critical milestone in the ongoing legal battles over intellectual property in the biotechnology sector. More details on this case can be found here.